Home LiteratureArticle Details
PMID: 15292349 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery.

The Journal of clinical endocrinology and metabolism ·Vol. 89 ·No. 8 ·2004-08-00 ·Pages 4062-8

van Dielen FM, Buurman WA, Hadfoune M, Nijhuis J, Greve JW

Abstract

Obesity is demonstrated to be associated with an enhanced inflammatory state, which is suggested to be a cause for the development of obesity-related morbidity. It was hypothesized that a decrease in body weight in morbid obese subjects would lead to a reduction of the inflammatory state in these subjects. Weight loss was achieved by gastric restrictive surgery in 27 morbidly obese patients. Preoperative as well as 3-, 6-, 12-, and 24-month postoperative plasma concentrations of inflammatory mediators macrophage inhibitory factor, plasminogen activator inhibitor-1, lipopolysaccharide binding protein, alpha-1 acid glycoprotein, C-reactive protein, soluble TNFalpha receptors 55 and 75, and leptin were measured. Macrophage inhibitory factor levels remained low normal for 6 months, during weight loss, after which they significantly increased to normal levels at 24 months postoperatively. The other inflammatory mediators remained elevated up to minimally 3 months postoperatively; thereafter they decreased significantly. Both TNFalpha receptors remained elevated up to at least 12 months postoperatively to decrease significantly at 2 yr postoperatively. This study demonstrates that during weight loss, after gastric restrictive surgery, inflammatory mediators remain elevated for at least 3 months postoperatively, suggesting initially an ongoing inflammatory state. However, 2 yr after surgery, the inflammatory mediators reach near normal values.These findings may be an explanation for the reduced comorbidity seen in morbidly obese patients after gastric restrictive surgery.

MeSH Terms
Acute-Phase Proteins/metabolism Adult C-Reactive Protein/metabolism Carrier Proteins/blood Gastroplasty Humans Leptin/blood Macrophage Migration-Inhibitory Factors/blood Membrane Glycoproteins Obesity, Morbid/surgery Orosomucoid/metabolism Plasminogen Activator Inhibitor 1/blood Postoperative Period Receptors, Tumor Necrosis Factor/chemistry,metabolism Solubility Tumor Necrosis Factor-alpha/metabolism Weight Loss
Chemicals
Acute-Phase Proteins Carrier Proteins Leptin Macrophage Migration-Inhibitory Factors Membrane Glycoproteins Orosomucoid Plasminogen Activator Inhibitor 1 Receptors, Tumor Necrosis Factor Tumor Necrosis Factor-alpha lipopolysaccharide-binding protein C-Reactive Protein
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
van Dielen F M H
Department of General Surgery, Nutrition Research Institute Maastricht and University Hospital Maastricht, 6202 AZ Maastricht, The Netherlands. f.vandielen@ah.unimaas.nl
Buurman W A
Hadfoune M
Nijhuis J
Greve J W
Article Info
Journal
The Journal of clinical endocrinology and metabolism
Abbr.
J Clin Endocrinol Metab
ISSN
0021-972X
Published
2004-08-00
Pages
4062-8
Language
English
Region
United States
NLM ID
0375362
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com